Technology | October 30, 2008

CadOne Mammography Solution Targets OEMs

CadOne is Three Palm Software’s mammography computer-aided detection (CAD) solution offered to original equipment manufacturers (OEM) for integration into their product suites.

For the end-user, this CAD product offers the following features:
- CadOne operates seamlessly within the mammography workflow
- CadOne offers three different operating points
- CadOne does not limit the number of views per study
- CAD reports include mass density and calcification cluster marks
- CAD reports optionally include information that can be utilized to enhance mammogram viewing capability: breast border; pectoral muscle border; nipple position; outlines of mass densities and calcifications
- Single CAD device can support multiple types of FFDM systems
- CAD reports are encoded as Mammography SR and can be displayed on standard Mammography workstations
- Throughput of 120 – 690 cases per hour on a dual-core CPU for a standard 4-view study with image resolutions ranging from 25µm to 100µm.

Most important technical specifications:
For a Healthcare Enterprise integrating Mammography CAD into its IT environment, CadOne offers the following features: DICOM MG (For Processing) source data; DICOM SR output; connectivity; dual-core 2.3GHz or higher; 1GB or more RAM.

For an OEM vendor adding CAD to its Mammography portfolio, CadOne offers the following features: software-only install; runs on a range of Windows platforms (including XP, Windows Server, Windows Vista); runs as a service and does not require any end-user interaction; can co-exist on a computer system with other services and end-user applications; stand-alone service tool; custom integration options (such as source data via private path; output in custom formats).

Related Content

Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
SimonMed Deploys ClearRead CT Enterprise Wide
News | Computer-Aided Detection Software | September 17, 2018
September 17, 2018 — National outpatient physician radiology group SimonMed Imaging has selected Riverain Technologie
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
FDA Issues Proposed Order to Reclassify Certain Radiological Medical Image Analyzers
News | Computer-Aided Detection Software | June 01, 2018
The U.S. Food and Drug Administration (FDA) is issuing a proposed order to reclassify certain radiological medical...
Median Technologies and the Nice University Hospital to Use AI in Lung Cancer Screening
News | Artificial Intelligence | March 15, 2018
March 15, 2018 – Median Technologies, the industry-leading Imaging Phenomics Company and the Nice University Hospital
FDA Clears First AI-Powered Clinical Decision Support Software for Stroke
Technology | Clinical Decision Support | February 14, 2018
The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact application, the first ...